Suven Life Sciences allots 3.17 cr equity shares on conversion of warrants

Suven Life Sciences has allotted 3,17,68,764 equity shares of Re 1 each on conversion of warrants. Post allotment, the paid up equity share capital has increased to 2637,20,583 equity shares of Re 1 each.

Powered by Capital Market - Live News